310 related articles for article (PubMed ID: 30871628)
21. KIR3DL1 and HLA-Bw4 Interaction Showed a Favorable Role in Patients with Myelodysplastic Syndromes in Chinese Southern Han.
Zhen JX; Cai SQ; Chen YT; Yang ZC; Zhuo JC; Deng ZH
Biomed Res Int; 2020; 2020():6215435. PubMed ID: 32420357
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.
Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Asadifar B
Iran J Immunol; 2010 Jun; 7(2):88-95. PubMed ID: 20574122
[TBL] [Abstract][Full Text] [Related]
23. HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19.
Wang R; Sun Y; Kuang BH; Yan X; Lei J; Lin YX; Tian J; Li Y; Xie X; Chen T; Zhang H; Zeng YX; Zhao J; Feng L
Emerg Microbes Infect; 2023 Dec; 12(1):2185467. PubMed ID: 36849422
[TBL] [Abstract][Full Text] [Related]
24. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
[TBL] [Abstract][Full Text] [Related]
25. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.
Al Omar S; Middleton D; Marshall E; Porter D; Xinarianos G; Raji O; Field JK; Christmas SE
Hum Immunol; 2010 Oct; 71(10):976-81. PubMed ID: 20600442
[TBL] [Abstract][Full Text] [Related]
26. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2
Wauquier N; Petitdemange C; Tarantino N; Maucourant C; Coomber M; Lungay V; Bangura J; Debré P; Vieillard V
EBioMedicine; 2019 Feb; 40():605-613. PubMed ID: 30711514
[TBL] [Abstract][Full Text] [Related]
27. Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory study.
La D; Czarnecki C; El-Gabalawy H; Kumar A; Meyers AF; Bastien N; Simonsen JN; Plummer FA; Luo M
PLoS One; 2011; 6(12):e29200. PubMed ID: 22216211
[TBL] [Abstract][Full Text] [Related]
28. The role genes encoding of killer cell immunoglobulin-like receptors (KIRs) and their ligands in susceptibility to and progression of HIV infection.
Błachowicz O; Zwolińska K
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1409-1423. PubMed ID: 28100849
[TBL] [Abstract][Full Text] [Related]
29. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
[TBL] [Abstract][Full Text] [Related]
30. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of KIR3DL1 expression levels on 92 cases of normal donors for hematopoietic stem cells transplant].
Zhang J; Wang M; Bao X; Wu X; Zhou H; Zhang H; Wu D; He J
Zhonghua Xue Ye Xue Za Zhi; 2015 Dec; 36(12):994-8. PubMed ID: 26759099
[TBL] [Abstract][Full Text] [Related]
32. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
[TBL] [Abstract][Full Text] [Related]
33. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
Kamya P; Boulet S; Tsoukas CM; Routy JP; Thomas R; Côté P; Boulassel MR; Baril JG; Kovacs C; Migueles SA; Connors M; Suscovich TJ; Brander C; Tremblay CL; Bernard N;
J Virol; 2011 Jun; 85(12):5949-60. PubMed ID: 21471235
[TBL] [Abstract][Full Text] [Related]
34. Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease.
Anderson KM; Augusto DG; Dandekar R; Shams H; Zhao C; Yusufali T; Montero-Martín G; Marin WM; Nemat-Gorgani N; Creary LE; Caillier S; Mofrad MRK; Parham P; Fernández-Viña M; Oksenberg JR; Norman PJ; Hollenbach JA
J Immunol; 2020 Sep; 205(5):1323-1330. PubMed ID: 32709660
[TBL] [Abstract][Full Text] [Related]
35. KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C.
Umemura T; Ota M; Katsuyama Y; Wada S; Mori H; Maruyama A; Shibata S; Nozawa Y; Kimura T; Morita S; Joshita S; Komatsu M; Matsumoto A; Kamijo A; Kobayashi M; Takamatsu M; Yoshizawa K; Kiyosawa K; Tanaka E
Hum Immunol; 2014 Aug; 75(8):822-6. PubMed ID: 24929144
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.
Hollenbach JA; Ladner MB; Saeteurn K; Taylor KD; Mei L; Haritunians T; McGovern DP; Erlich HA; Rotter JI; Trachtenberg EA
Immunogenetics; 2009 Oct; 61(10):663-71. PubMed ID: 19789864
[TBL] [Abstract][Full Text] [Related]
37. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P
Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
[TBL] [Abstract][Full Text] [Related]
38. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands.
Jennes W; Verheyden S; Demanet C; Adjé-Touré CA; Vuylsteke B; Nkengasong JN; Kestens L
J Immunol; 2006 Nov; 177(10):6588-92. PubMed ID: 17082569
[TBL] [Abstract][Full Text] [Related]
39. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.
Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ
Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065
[TBL] [Abstract][Full Text] [Related]
40. Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients.
Joshita S; Ota M; Kobayashi H; Wakabayashi SI; Yamashita Y; Sugiura A; Yamazaki T; Tanaka E; Umemura T
Sci Rep; 2021 Nov; 11(1):21424. PubMed ID: 34728722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]